Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,062 | 55,742 | 60,809 | 62,001 | 56,210 |
| Marketable Securities | 1,882 | 2,616 | 4,295 | 6,745 | 6,154 |
| Receivables | 515 | 50,840 | 79 | 326 | 109 |
| TOTAL | $81,872 | $111,549 | $68,344 | $71,577 | $64,622 |
| Non-Current Assets | |||||
| PPE Net | 4,548 | 4,872 | 4,728 | 5,008 | 5,114 |
| Intangibles | 57,461 | 57,494 | 57,526 | 57,559 | 57,591 |
| Other Non-Current Assets | 639 | 630 | 614 | 610 | 601 |
| TOTAL | $62,648 | $62,996 | $62,868 | $63,177 | $63,306 |
| Total Assets | $144,520 | $174,545 | $131,212 | $134,754 | $127,928 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,957 | 27,969 | 6,705 | 5,348 | 5,733 |
| Other current liabilities | 14,886 | 197 | 293 | N/A | 102 |
| TOTAL | $24,593 | $47,116 | $8,791 | $6,768 | $6,621 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 18,119 | 975 | 613 | N/A |
| Other Non-Current Liabilities | 1,792 | 2,171 | 50 | 2,470 | 2,667 |
| TOTAL | $34,709 | $36,531 | $2,832 | $4,385 | $4,737 |
| Total Liabilities | $59,302 | $83,647 | $11,623 | $11,153 | $11,358 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 169,727 | 169,709 | 168,558 | 167,460 | 162,141 |
| Common Shares | 435,818 | 434,529 | 432,250 | 428,046 | 415,259 |
| Retained earnings | -344,184 | -337,097 | -308,105 | -300,282 | -295,494 |
| Other shareholders' equity | -6,416 | -6,534 | -4,556 | -4,163 | -3,195 |
| TOTAL | $85,218 | $90,898 | $119,589 | $123,601 | $116,570 |
| Total Liabilities And Equity | $144,520 | $174,545 | $131,212 | $134,754 | $127,928 |